Home

Insights

Abbott India Ltd P/E Ratio

Abbott India Ltd P/E Ratio

download
stocks purchased

₹ 0.1 Cr

Volume transacted

stocks purchased

0.0 K

stocks traded

Image

Abbott India Ltd

NSE: ABBOTINDIA

PE

47.8

Last updated : 18 May 13:20 PM

Key Highlights

    The P/E Ratio of Abbott India Ltd is 47.8 as of 18 May 13:20 PM .a1#The P/E Ratio of Abbott India Ltd changed from 34.4 on March 2019 to 49.4 on March 2023 . This represents a CAGR of 7.51% over 5 years. a1#The Latest Trading Price of Abbott India Ltd is ₹ 26643 as of 18 May 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.7 to 27.7 in 5 years. This represents a CAGR of -0.71%a1# The PE Ratio of Automobile industry is 27.2. The PE Ratio of Finance industry is 13.6. The PE Ratio of IT - Software industry is 27.9. The PE Ratio of Pharmaceuticals industry is 27.7. The PE Ratio of Retail industry is 94.8. The PE Ratio of Textiles industry is 21.1. In 2023a1#The Market Cap of Abbott India Ltd changed from ₹ 15505 crore on March 2019 to ₹ 46933 crore on March 2023 . This represents a CAGR of 24.80% over 5 years. a1#The Revenue of Abbott India Ltd changed from ₹ 1330 crore to ₹ 1519 crore over 8 quarters. This represents a CAGR of 6.87% a1#The EBITDA of Abbott India Ltd changed from ₹ 296.76 crore to ₹ 410.68 crore over 8 quarters. This represents a CAGR of 17.64% a1#The Net Profit of Abbott India Ltd changed from ₹ 205.64 crore to ₹ 287.06 crore over 8 quarters. This represents a CAGR of 18.15% a1#The Dividend Payout of Abbott India Ltd changed from 30.67 % on March 2019 to 72.74 % on March 2023 . This represents a CAGR of 18.85% over 5 years. a1#

Open Demat Account

Lead form image

+91

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

*By signing up you agree to our terms & conditions

×

P/E Ratio Over Time

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

P/E Ratio Over Time

Period
Mar '1934.4
Mar '2055.4
Mar '2146.1
Mar '2247.1
Mar '2349.4

Fundamental Metrics

Market Cap

56,291 Cr

EPS

565.3

P/E Ratio (TTM) *

47.8

P/B Ratio (TTM) *

15.5

Day’s High

26721.7

Day’s Low

26506.05

DTE *

0.0

ROE *

32.5

52 Week High

29628.15

52 Week Low

20594.25

ROCE *

43.1

* All values are consolidated

* All values are consolidated

Image

Abbott India Ltd

NSE: ABBOTINDIA

PRICE

26643.7

153.50(0.58%)

stock direction

Last updated : 18 May 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Abbott India Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value

Market Value

57,467

Asset Value

3,050

17.8 X

Value addition

* All values are in Rupees

PE Ratio Over Market Cap

Key Valuation Metric

Earnings

1,201 Cr

47.8 X

PE Ratio

Market Cap

₹57467Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio

PS Ratio

PB Ratio

Earnings

1,201 Cr

47.8 X

PE Ratio

Market Cap

₹57467Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Abbott India Ltd PE Ratio Calculation

  • The Price-to-Earnings (PE) ratio, also known as the P/E Ratio, is a fundamental financial metric used to assess the valuation of a company's stock in relation to its earnings performance. For Abbott India Ltd, the PE Ratio is calculated as follows:

P/E Ratio

=

Market Capitalization

Net Income

  • Given the current market conditions, Abbott India Ltd's Share Price stands at 26643.7. The Earnings per Share (Diluted) for the trailing twelve months (TTM) ending in 2024-05-18T00:00:00 is 565.28. Substituting the values into the formula, PE Ratio becomes as follows: PE Ratio = 26643.7/ 565.28= 47.84.

P/E Ratio

=

Stock Price

Earning Per Share

  • This indicates that Abbott India Ltd's stock is trading at approximately 47.84 times its earnings per share for the trailing twelve months. Alternatively, the PE Ratio can also be computed using the company's overall financial performance: PE Ratio = Market Cap / Net Income. Where Market Cap represents the total market capitalization of the company, and Net Income signifies the total earnings after expenses and taxes.

Understanding Abbott India Ltd’s PE Ratio (BSE: ABBOTINDIA)

    The Price-to-Earnings (PE) ratio, used to assess Abbott India Ltd's stock (BSE: ABBOTINDIA), indicates how many years it would take for the company to earn back the stock price. If a company earns ₹2 per share annually and its stock trades at ₹30, the PE ratio is 15, signifying a 15-year payback period assuming steady earnings. Earnings fluctuate, affecting the payback period, Growing earnings shorten the recovery time while declining earnings extend it. Shareholders favor shorter payback periods, preferring lower PE stocks. Among stocks with the same PE ratio, faster-growing businesses are preferred. A company with losses makes the PE ratio meaningless. Peter Lynch introduced the PEG ratio to compare stocks with different growth rates, dividing the PE ratio by the growth rate. A company is considered fairly valued when its PE ratio matches its growth rate. The PE ratio, applicable across industries, measures stock valuation based on earnings power. It indicates how quickly an investment can be recouped. Unlike the PB ratio, which assesses valuation based on the balance sheet, the PE ratio focuses on earnings. Overall, the PE ratio provides insights into stock valuation, aligning with investors' preference for faster returns.

×

Market Cap Over Time

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Market Cap Over Time

Period
Mar '1915506
Mar '2032843
Mar '2131851
Mar '2237611
Mar '2346934

* All values are a in crore

×

Revenue Over Time

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Revenue Over Time

Period
Jun '221331
Sep '221413
Dec '221366
Mar '221393
Jun '231535
Sep '231550
Dec '231493
Mar '231520

* All values are a in crore

×

EBITDA Over Time

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

EBITDA Over Time

Period
Jun '22297
Sep '22377
Dec '22356
Mar '22330
Jun '23411
Sep '23436
Dec '23443
Mar '23411

* All values are a in crore

×

Net Profit Over Time

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Net Profit Over Time

Period
Jun '22206
Sep '22266
Dec '22247
Mar '22231
Jun '23290
Sep '23313
Dec '23311
Mar '23287

* All values are a in crore

×

Dividend Payout Over Time

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Dividend Payout Over Time

Period
Mar '1931
Mar '2090
Mar '2185
Mar '2273
Mar '2373

* All values are a in %

About Abbott India Ltd

About Abbott India Ltd

    It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc. The Specialty Care-Neuroscience division has a varied portfolio with specialty products in neurology and psychiatric segments. In the year 2004, the company started the production of Capsules with the capacity of 27 Millions Nos. This was possible through stellar performance in key brands: Betonin, Kinetone, Digecaine and Digene growing faster than their participated market. During the financial year ended 31 March 2017, Abbott India launched 10 new products in various therapy segments, which contributed 0.7% of the sales of the company. The GI Prospera division launched 3 new products - Velpaclear (Hepatitis C), Antoxipan (Pain Management in chronic pancreatitis) and Heptral T (ALD/NAFLD). During the FY2019,the company executed 25 new studies, published 45 articles in major indexed journals, with 6 international presentations. During the FY2021, there was a innovation in Brufen Coating formula which led to 50% increase in coating Installed capacity in 2 shifts from 675 mio tabs to 1,012 mio tabs without any capex. During the year 2022, company continued portfolio expansion and launched 10 new differentiated products in the market to meet increasing healthcare needs. It increased presence in high growth therapy areas such as adult vaccination and new sub-therapies like menopause. New products like Femoston Mini (post-menopausal symptoms), Solfe extra tablet (iron deficiency anemia) and Cetropro vial (IVF) were launched on Women's health portfolio during the year 2023.

Abbott India Ltd News Hub

News

Abbott India to hold AGM

Abbott India announced that the 80th Annual General Meeting(AGM) of the company will be he...

Read more

10 May 2024 09:34

News

Board of Abbott India recommends final dividend

Abbott India announced that the Board of Directors of the Company at its meeting held on 9...

Read more

10 May 2024 09:34

News

Abbott India edges higher after board OKs dividend of Rs 410/share; Q4 PAT rises 24% YoY

The record date for the same is Friday, 19 July 2024. The dividend would be paid on or aft...

Read more

10 May 2024 09:41

News

Abbott India Ltd up for fifth session

Abbott India Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2...

Read more

02 May 2024 13:00

News

Abbott India to table results

Abbott India will hold a meeting of the Board of Directors of the Company on 9 May 2024. P...

Read more

29 Apr 2024 17:15

News

Abbott India appoints Commercial Director - Women's Health, Metabolics and International Business

The Board of Abbott India has appointed Murari Ranganathan as Commercial Director - Women'...

Read more

12 Apr 2024 10:06

Product Composition by Percentage (Revenue)

FAQs for PE of Abbott India Ltd

What is Abbott India Ltd current share price?

The current market price of Abbott India Ltd as of May 18, 2024 is ₹26643.70.

What is Abbott India Ltd's market cap?

Abbott India Ltd's market capitalisation stood at ₹57,467 Cr as of May 18, 2024

What are Abbott India Ltd's total net assets?

According to Abbott India Ltd's most recent financial filings, the company's net assets total ₹3050.2 Cr.

Is Abbott India Ltd making a profit or loss?

Abbott India Ltd's net Profit as of May 18, 2024 is close to ₹1,201 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199